[{"id":"41426191-e861-4497-bd26-22264d4bdb1e","acronym":"","url":"https://clinicaltrials.gov/study/NCT05933668","created_at":"2023-07-06T16:10:24.750Z","updated_at":"2024-07-02T16:35:43.789Z","phase":"Phase 1","brief_title":"Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Solid Tumor","source_id_and_acronym":"NCT05933668","lead_sponsor":"Peking University","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS G12V • KRAS G12","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS G12V • KRAS G12"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • oxaliplatin • YK0901"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 11","initiation":"Initiation: 07/01/2023","start_date":" 07/01/2023","primary_txt":" Primary completion: 07/01/2024","primary_completion_date":" 07/01/2024","study_txt":" Completion: 07/01/2026","study_completion_date":" 07/01/2026","last_update_posted":"2023-07-06"}]